These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33357592)

  • 1. Clinical features of spinal muscular atrophy (SMA) type 2.
    Cancès C; Richelme C; Barnerias C; Espil C
    Arch Pediatr; 2020 Dec; 27(7S):7S18-7S22. PubMed ID: 33357592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and surgical treatments in patients with spinal muscular atrophy (SMA).
    Boulay C; Peltier E; Jouve JL; Pesenti S
    Arch Pediatr; 2020 Dec; 27(7S):7S35-7S39. PubMed ID: 33357596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of spinal muscular atrophy (SMA) type 3 (Kugelberg-Welander disease).
    Salort-Campana E; Quijano-Roy S
    Arch Pediatr; 2020 Dec; 27(7S):7S23-7S28. PubMed ID: 33357593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal muscular atrophy (SMA) type I (Werdnig-Hoffmann disease).
    Audic F; Barnerias C
    Arch Pediatr; 2020 Dec; 27(7S):7S15-7S17. PubMed ID: 33357591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical aspects in the care of a child with infantile spinal muscular atrophy (SMA).
    Chabrol B; Desguerre I
    Arch Pediatr; 2020 Dec; 27(7S):7S50-7S53. PubMed ID: 33357599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State of the art for motor function assessment tools in spinal muscular atrophy (SMA).
    Vuillerot C
    Arch Pediatr; 2020 Dec; 27(7S):7S40-7S44. PubMed ID: 33357597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidisciplinary approach and psychosocial management of spinal muscular atrophy (SMA).
    Ropars J; Peudenier S; Genot A; Barnerias C; Espil C
    Arch Pediatr; 2020 Dec; 27(7S):7S45-7S49. PubMed ID: 33357598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory management of children with spinal muscular atrophy (SMA).
    Fauroux B; Griffon L; Amaddeo A; Stremler N; Mazenq J; Khirani S; Baravalle-Einaudi M
    Arch Pediatr; 2020 Dec; 27(7S):7S29-7S34. PubMed ID: 33357594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and therapeutic targets in spinal muscular atrophy (SMA).
    Lefebvre S; Sarret C
    Arch Pediatr; 2020 Dec; 27(7S):7S3-7S8. PubMed ID: 33357595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory capacity course in patients with infantile spinal muscular atrophy.
    Ioos C; Leclair-Richard D; Mrad S; Barois A; Estournet-Mathiaud B
    Chest; 2004 Sep; 126(3):831-7. PubMed ID: 15364763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular diagnosis and genetic counseling for spinal muscular atrophy (SMA).
    Rouzier C; Chaussenot A; Paquis-Flucklinger V
    Arch Pediatr; 2020 Dec; 27(7S):7S9-7S14. PubMed ID: 33357600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical presentations of spinal muscular atrophy type III (Kugelberg-Welander disease).
    Kang PB; Krishnamoorthy KS; Jones RM; Shapiro FD; Darras BT
    Neuromuscul Disord; 2006 Aug; 16(8):492-4. PubMed ID: 16797181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value of achieved motor milestones assessed in 441 patients with infantile spinal muscular atrophy types II and III.
    Rudnik-Schöneborn S; Hausmanowa-Petrusewicz I; Borkowska J; Zerres K
    Eur Neurol; 2001; 45(3):174-81. PubMed ID: 11306862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome measures in spinal muscular atrophy.
    Montes J; Gordon AM; Pandya S; De Vivo DC; Kaufmann P
    J Child Neurol; 2009 Aug; 24(8):968-78. PubMed ID: 19509409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4.
    Wadman RI; Wijngaarde CA; Stam M; Bartels B; Otto LAM; Lemmink HH; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
    Eur J Neurol; 2018 Mar; 25(3):512-518. PubMed ID: 29194869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal muscular atrophy: survival pattern and functional status.
    Chung BH; Wong VC; Ip P
    Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of 83 cases with spinal muscular atrophy in children].
    Li H; Wang HL; Shan CM
    Zhonghua Er Ke Za Zhi; 2004 Oct; 42(10):762-4. PubMed ID: 16221347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care.
    Mercuri E; Finkel RS; Muntoni F; Wirth B; Montes J; Main M; Mazzone ES; Vitale M; Snyder B; Quijano-Roy S; Bertini E; Davis RH; Meyer OH; Simonds AK; Schroth MK; Graham RJ; Kirschner J; Iannaccone ST; Crawford TO; Woods S; Qian Y; Sejersen T;
    Neuromuscul Disord; 2018 Feb; 28(2):103-115. PubMed ID: 29290580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural course of scoliosis in proximal spinal muscular atrophy type II and IIIa: descriptive clinical study with retrospective data collection of 126 patients.
    Fujak A; Raab W; Schuh A; Richter S; Forst R; Forst J
    BMC Musculoskelet Disord; 2013 Oct; 14():283. PubMed ID: 24093531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle strength and motor function in children and adolescents with spinal muscular atrophy II and III.
    Kroksmark AK; Beckung E; Tulinius M
    Eur J Paediatr Neurol; 2001; 5(5):191-8. PubMed ID: 11585107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.